157 related articles for article (PubMed ID: 20402561)
1. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
Lewis DF; Ito Y
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
[TBL] [Abstract][Full Text] [Related]
2. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
Lewis DF; Ito Y
Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
[TBL] [Abstract][Full Text] [Related]
3. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
Lewis DF; Jacobs MN; Dickins M
Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
[TBL] [Abstract][Full Text] [Related]
4. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B; Chow D; Hu M
Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
[TBL] [Abstract][Full Text] [Related]
5. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
6. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B
Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
[TBL] [Abstract][Full Text] [Related]
7. A role for CYP in the drug-hormone crosstalk of the brain.
Meyer RP; Gehlhaus M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):675-87. PubMed ID: 20201748
[TBL] [Abstract][Full Text] [Related]
8. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
10. In silico predictive metabolism: a structural/electronic filter method.
Harris DL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.
Ekins S; de Groot MJ; Jones JP
Drug Metab Dispos; 2001 Jul; 29(7):936-44. PubMed ID: 11408357
[TBL] [Abstract][Full Text] [Related]
12. Use of density functional theory in drug metabolism studies.
Rydberg P; Jørgensen FS; Olsen L
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
[TBL] [Abstract][Full Text] [Related]
13. Regioselectivity prediction of CYP1A2-mediated phase I metabolism.
Jung J; Kim ND; Kim SY; Choi I; Cho KH; Oh WS; Kim DN; No KT
J Chem Inf Model; 2008 May; 48(5):1074-80. PubMed ID: 18412330
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
Murray M
Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
[TBL] [Abstract][Full Text] [Related]
15. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.
Cruciani G; Carosati E; De Boeck B; Ethirajulu K; Mackie C; Howe T; Vianello R
J Med Chem; 2005 Nov; 48(22):6970-9. PubMed ID: 16250655
[TBL] [Abstract][Full Text] [Related]
16. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
McGinnity DF; Parker AJ; Soars M; Riley RJ
Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
[TBL] [Abstract][Full Text] [Related]
17. Do Fukui function maxima relate to sites of metabolism? A critical case study.
Beck ME
J Chem Inf Model; 2005; 45(2):273-82. PubMed ID: 15807488
[TBL] [Abstract][Full Text] [Related]
18. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.
McGinnity DF; Griffin SJ; Moody GC; Voice M; Hanlon S; Friedberg T; Riley RJ
Drug Metab Dispos; 1999 Sep; 27(9):1017-23. PubMed ID: 10460801
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
20. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
Muruganandan S; Sinal CJ
Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]